Karyopharm Therapeutics
KPTI
KPTI
88 hedge funds and large institutions have $415M invested in Karyopharm Therapeutics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
2% less funds holding
Funds holding: 90 → 88 (-2)
Holders
88
Holding in Top 10
–
Calls
$2.65M
Puts
$2.7M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$10.3M | |
| 3 | +$7.52M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.36M |
| 5 |
DAM
Doheny Asset Management
Los Angeles,
California
|
+$3.07M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$17.3M | |
| 3 | -$12.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.46M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$2.35M |